MAEL in human cancers and implications in prognostication and predicting benefit from immunotherapy over VEGFR/mTOR inhibitors in clear cell renal cell carcinoma: a bioinformatic analysis.

Authors:
Tao J; Cui J; Xu Y; Fan Y; Hong G and 8 more

Journal:
Aging (Albany NY)

Publication Year: 2024

DOI:
10.18632/aging.205470

PMCID:
PMC10911358

PMID:
38301040

Journal Information

Full Title: Aging (Albany NY)

Abbreviation: Aging (Albany NY)

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Geriatrics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICTS OF INTEREST: The authors declare no potential conflicts of interest, except the employment of Yu Xu, Qiaoxia Zhou, Guoqiang Wang, Leo Li, Yusheng Han, and Shangli Cai in Burning Rock Biotech."

Evidence found in paper:

"FUNDING: This work was supported by 2018 Entrepreneurial Leading Talent of Guangzhou Huangpu District and Guangzhou Development District (2022-L023 to Yusheng Han)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025